Pathological processes in the COLON region of the large intestine (INTESTINE, LARGE).
A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.
A solution or compound that is introduced into the RECTUM with the purpose of cleansing the COLON or for diagnostic procedures.
Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.
The distal segment of the LARGE INTESTINE, between the SIGMOID COLON and the ANAL CANAL.
Endoscopic examination, therapy or surgery of the luminal surface of the colon.
Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI.
Chronic or recurrent colonic disorders without an identifiable structural or biochemical explanation. The widely recognized IRRITABLE BOWEL SYNDROME falls into this category.
Tumors or cancer of the COLON.
Discrete tissue masses that protrude into the lumen of the COLON. These POLYPS are connected to the wall of the colon either by a stalk, pedunculus, or by a broad base.
Congenital MEGACOLON resulting from the absence of ganglion cells (aganglionosis) in a distal segment of the LARGE INTESTINE. The aganglionic segment is permanently contracted thus causing dilatation proximal to it. In most cases, the aganglionic segment is within the RECTUM and SIGMOID COLON.
Receptor protein-tyrosine kinases involved in the signaling of GLIAL CELL-LINE DERIVED NEUROTROPHIC FACTOR ligands. They contain an extracellular cadherin domain and form a receptor complexes with GDNF RECEPTORS. Mutations in ret protein are responsible for HIRSCHSPRUNG DISEASE and MULTIPLE ENDOCRINE NEOPLASIA TYPE 2.
Two ganglionated neural plexuses in the gut wall which form one of the three major divisions of the autonomic nervous system. The enteric nervous system innervates the gastrointestinal tract, the pancreas, and the gallbladder. It contains sensory neurons, interneurons, and motor neurons. Thus the circuitry can autonomously sense the tension and the chemical environment in the gut and regulate blood vessel tone, motility, secretions, and fluid transport. The system is itself governed by the central nervous system and receives both parasympathetic and sympathetic innervation. (From Kandel, Schwartz, and Jessel, Principles of Neural Science, 3d ed, p766)
A subclass of closely-related SOX transcription factors. Members of this subfamily have been implicated in regulating the differentiation of OLIGODENDROCYTES during neural crest formation and in CHONDROGENESIS.
A family of GLYCOSYLPHOSPHATIDYLINOSITOL-anchored cell surface receptors that are specific for GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTORS. They form a multi-component receptor complex with PROTO-ONCOGENE PROTEIN C-RET and regulate a variety of intracellular SIGNAL TRANSDUCTION PATHWAYS in conjunction with c-ret protein.
A subtype of endothelin receptor found predominantly in the KIDNEY. It may play a role in reducing systemic ENDOTHELIN levels.
Rare, autosomal dominant disease with variable penetrance and several known clinical types. Characteristics may include depigmentation of the hair and skin, congenital deafness, heterochromia iridis, medial eyebrow hyperplasia, hypertrophy of the nasal root, and especially dystopia canthorum. The underlying cause may be defective development of the neural crest (neurocristopathy). Waardenburg's syndrome may be closely related to piebaldism. Klein-Waardenburg Syndrome refers to a disorder that also includes upper limb abnormalities.
I'm sorry for any confusion, but "Kentucky" is a proper noun and not a term that has a medical definition. It is a state located in the eastern region of the United States. If you have any questions related to medical conditions or terminology, I would be happy to help answer those!
A collective genome representative of the many organisms, primarily microorganisms, existing in a community.
The full collection of microbes (bacteria, fungi, virus, etc.) that naturally exist within a particular biological niche such as an organism, soil, a body of water, etc.
Generally refers to the digestive structures stretching from the MOUTH to ANUS, but does not include the accessory glandular organs (LIVER; BILIARY TRACT; PANCREAS).
Short-chain fatty acids of up to six carbon atoms in length. They are the major end products of microbial fermentation in the ruminant digestive tract and have also been implicated in the causation of neurological diseases in humans.
A non-fibrillar collagen that forms a network of MICROFIBRILS within the EXTRACELLULAR MATRIX of CONNECTIVE TISSUE. The alpha subunits of collagen type VI assemble into antiparallel, overlapping dimers which then align to form tetramers.
Derivatives of BUTYRIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxypropane structure.

The role of psychological and biological factors in postinfective gut dysfunction. (1/304)

BACKGROUND: Both psychological and physiological disturbances have been implicated in the aetiopathogenesis of irritable bowel syndrome (IBS). AIMS: To investigate how the psychological factors act, and the involvement of infective and physiological factors. METHODS: Consecutive patients hospitalised for gastroenteritis reported life events for the previous 12 months, and past illness experiences on standardised questionnaires. They also completed psychometric questionnaires for anxiety, neuroticism, somatisation, and hypochondriasis. In some patients, rectal biopsy specimens were obtained during the acute illness and at three months postinfection. RESULTS: Ninety four patients completed all questionnaires: 22 patients were diagnosed with IBS after their gastroenteritis (IBS+), and 72 patients returned to normal bowel habits (IBS-). IBS+ patients reported more life events and had higher hypochondriasis scores than IBS- patients. The predictive value of the life event and hypochondriasis measures was highly significant and independent of anxiety, neuroticism, and somatisation scores, which were also elevated in IBS+ patients. Rectal biopsy specimens from 29 patients showed a chronic inflammatory response in both IBS+ and IBS- patients. Three months later, specimens from IBS+ patients continued to show increased chronic inflammatory cell counts but those from IBS- patients had returned to normal levels. IBS+ and IBS- patients exhibited rectal hypersensitivity and hyper-reactivity and rapid colonic transit compared with normal controls, but there were no significant differences between IBS+ and IBS- patients for these physiological measurements. CONCLUSION: Psychological factors most clearly predict the development of IBS symptoms after gastroenteritis but biological mechanisms also contribute towards the expression of symptoms.  (+info)

Validation of a specific quality of life questionnaire for functional digestive disorders. (2/304)

BACKGROUND: Dyspepsia and irritable bowel syndrome are suitable conditions for assessment of quality of life. Their similarities justify the elaboration of a single specific questionnaire for the two conditions. AIMS: To examine the process leading to the validation of the psychometric properties of the functional digestive disorders quality of life questionnaire (FDDQL). METHODS: Initially, the questionnaire was given to 154 patients, to assess its acceptability and reproducibility, analyse its content, and reduce the number of items. Its responsiveness was tested during two therapeutic trials which included 428 patients. The questionnaire has been translated into French, English, and German. The psychometric validation study was conducted in France, United Kingdom, and Germany by 187 practitioners. A total of 401 patients with dyspepsia or irritable bowel syndrome, defined by the Rome criteria, filled in the FDDQL and generic SF-36 questionnaires. RESULTS: The structure of the FDDQL scales was checked by factorial analysis. Its reliability was expressed by a Cronbach's alpha coefficient of 0.94. Assessment of its discriminant validity showed that the more severe the functional digestive disorders, the more impaired the quality of life (p<0.05). Concurrent validity was supported by the correlation found between the FDDQL and SF-36 questionnaire scales. The final version of the questionnaire contains 43 items belonging to eight domains. CONCLUSIONS: The properties of the FDDQL questionnaire, available in French, English, and German, make it appropriate for use in clinical trials designed to evaluate its responsiveness to treatment among patients with dyspepsia and irritable bowel syndrome.  (+info)

Determination of prostaglandin synthetase activity in rectal biopsy material and its significance in colonic disease. (3/304)

A method is described for determining prostaglandin synthetase activity in milligram amounts of tissue. The procedure is based on the conversion of 14C-arachidonic acid to prostaglandin E2 and F2alpha-like substances. High levels of prostaglandin synthetase activity occurred in the inflamed mucosa of patients with ulcerative colitis and fell during successful drug therapy, but it is not yet known whether the cause of the inflammation first involves increased PG synthetase activity, or whether inflammation caused increase of PG synthetase.  (+info)

Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. (4/304)

BACKGROUND: Life stress contributes to symptom onset and exacerbation in the majority of patients with irritable bowel syndrome (IBS) and functional dyspepsia (FD); research evidence is conflicting, however, as to the strength of these effects. AIMS: To test prospectively the relation of chronic life stress threat to subsequent symptom intensity over time. PATIENTS: One hundred and seventeen consecutive outpatients satisfying the modified Rome criteria for IBS (66% with one or more concurrent FD syndromes) participated. METHODS: The life stress and symptom intensity measures were determined from interview data collected independently at entry, and at six and 16 months; these measures assessed the potency of chronic life stress threat during the prior six months or more, and the severity and frequency of IBS and FD symptoms during the following two weeks. RESULTS: Chronic life stress threat was a powerful predictor of subsequent symptom intensity, explaining 97% of the variance on this measure over 16 months. No patient exposed to even one chronic highly threatening stressor improved clinically (by 50%) over the 16 months; all patients who improved did so in the absence of such a stressor. CONCLUSION: The level of chronic life stress threat predicts the clinical outcome in most patients with IBS/FD.  (+info)

Functional disability in adolescents and young adults with symptoms of irritable bowel syndrome: the role of academic, social, and athletic competence. (5/304)

OBJECTIVE: To examine perceived academic, social, and athletic competence as potential moderators of the relation between symptoms of irritable bowel syndrome (IBS) and functional disability in adolescents and young adults with a history of recurrent abdominal pain (RAP). METHODS: We assessed IBS symptoms, competence, and disability by telephone interview in RAP patients five years following their medical evaluation. RESULTS: For both male and female subjects, the relation between symptoms and disability was stronger at lower levels of perceived academic competence. Furthermore, among females, the relation between symptoms and disability was stronger at lower levels of perceived social competence; among males, the relation was stronger at lower levels of perceived athletic competence. CONCLUSIONS: Perceived competence moderated the relation between IBS symptoms and functional disability. Interventions designed to enhance patient competence in various roles may be useful in reducing disability among adolescents and young adults with symptoms of IBS.  (+info)

Controlled trial of oligofructose in the management of irritable bowel syndrome. (6/304)

A double-blind crossover trial of oligofructose (Raftilose P95) 2 g three times daily against sucrose (1 g) three times daily was performed in patients suffering from irritable bowel syndrome. Each treatment was followed for 4 wk. Patients consumed a standardized diet during the last 14 d of each treatment period, and symptoms were assessed using a previously validated questionnaire. Fecal weight and pH, whole-gut transit time and fasting breath hydrogen concentrations were measured at the start of the study and at the end of each treatment period. Oligofructose produced no significant change in any of these parameters even when patients were divided into those with predominant diarrhea (n = 14) and those with predominant constipation (n = 7). Oligofructose at a dose of 6 g/d had no therapeutic value in patients with irritable bowel syndrome.  (+info)

Recommendations for the management of irritable bowel syndrome in family practice. IBS Consensus Conference Participants. (7/304)

To help family physicians manage patients with irritable bowel syndrome (IBS), a consensus conference was convened in June 1997 at which 5 internationally recognized experts in IBS presented position papers on selected topics previously circulated to the conference participants. Five working groups comprising family physicians, gastroenterologists and allied health care professionals from across Canada were then charged with developing recommendations for the diagnosis, patient education, psychosocial management, dietary advice and pharmacotherapy, respectively. An evidence-based approach was used where possible; otherwise, recommendations were made by consensus. The participants concluded that family physicians can make a positive diagnosis of IBS using symptom criteria. The pathophysiology is poorly understood, but motility and sensory disturbances appear to play a role. Neither psychological nor specific dietary factors cause IBS, but both can trigger symptoms. Drug therapy is not recommended for the routine treatment of IBS, but short-term trials of drug therapy may be targeted to predominant symptoms in selected patients. A step-wise, patient-centred approach to management is outlined.  (+info)

Fundamentals of neurogastroenterology. (8/304)

Current concepts and basic principles of neurogastroenterology in relation to functional gastrointestinal disorders are reviewed. Neurogastroenterology is emphasized as a new and advancing subspecialty of clinical gastroenterology and digestive science. As such, it embraces the investigative sciences dealing with functions, malfunctions, and malformations in the brain and spinal cord, and the sympathetic, parasympathetic and enteric divisions of the autonomic innervation of the digestive tract. Somatomotor systems are included insofar as pharyngeal phases of swallowing and pelvic floor involvement in defecation, continence, and pelvic pain are concerned. Inclusion of basic physiology of smooth muscle, mucosal epithelium, and the enteric immune system in the neurogastroenterologic domain relates to requirements for compatibility with neural control mechanisms. Psychologic and psychiatric relations to functional gastrointestinal disorders are included because they are significant components of neurogastroenterology, especially in relation to projections of discomfort and pain to the digestive tract.  (+info)

Colonic diseases refer to a group of medical conditions that affect the colon, also known as the large intestine or large bowel. The colon is the final segment of the digestive system, responsible for absorbing water and electrolytes, and storing and eliminating waste products.

Some common colonic diseases include:

1. Inflammatory bowel disease (IBD): This includes conditions such as Crohn's disease and ulcerative colitis, which cause inflammation and irritation in the lining of the digestive tract.
2. Diverticular disease: This occurs when small pouches called diverticula form in the walls of the colon, leading to symptoms such as abdominal pain, bloating, and changes in bowel movements.
3. Colorectal cancer: This is a type of cancer that develops in the colon or rectum, often starting as benign polyps that grow and become malignant over time.
4. Irritable bowel syndrome (IBS): This is a functional gastrointestinal disorder characterized by abdominal pain, bloating, and changes in bowel movements, but without any underlying structural or inflammatory causes.
5. Constipation: This is a common condition characterized by infrequent bowel movements, difficulty passing stools, or both.
6. Infectious colitis: This occurs when the colon becomes infected with bacteria, viruses, or parasites, leading to symptoms such as diarrhea, abdominal cramps, and fever.

Treatment for colonic diseases varies depending on the specific condition and its severity. Treatment options may include medications, lifestyle changes, surgery, or a combination of these approaches.

Crohn's disease is a type of inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract, from the mouth to the anus. It is characterized by chronic inflammation of the digestive tract, which can lead to symptoms such as abdominal pain, diarrhea, fatigue, weight loss, and malnutrition.

The specific causes of Crohn's disease are not fully understood, but it is believed to be related to a combination of genetic, environmental, and immune system factors. The disease can affect people of any age, but it is most commonly diagnosed in young adults between the ages of 15 and 35.

There is no cure for Crohn's disease, but treatments such as medications, lifestyle changes, and surgery can help manage symptoms and prevent complications. Treatment options depend on the severity and location of the disease, as well as the individual patient's needs and preferences.

The colon, also known as the large intestine, is a part of the digestive system in humans and other vertebrates. It is an organ that eliminates waste from the body and is located between the small intestine and the rectum. The main function of the colon is to absorb water and electrolytes from digested food, forming and storing feces until they are eliminated through the anus.

The colon is divided into several regions, including the cecum, ascending colon, transverse colon, descending colon, sigmoid colon, rectum, and anus. The walls of the colon contain a layer of muscle that helps to move waste material through the organ by a process called peristalsis.

The inner surface of the colon is lined with mucous membrane, which secretes mucus to lubricate the passage of feces. The colon also contains a large population of bacteria, known as the gut microbiota, which play an important role in digestion and immunity.

An enema is a medical procedure in which liquid is introduced into the lower part of the large intestine, specifically the sigmoid colon or rectum, through the anus using a special device called an enema kit. The liquid used can be plain water, saline solution, or a medicated solution, and it is typically retained for a short period of time before being expelled.

The purpose of an enema may vary, but it is often used to relieve constipation, prepare the bowel for medical procedures such as colonoscopy, or administer medications or nutrients that cannot be taken by mouth. Enemas can also be used for therapeutic purposes, such as to stimulate the immune system or promote relaxation.

It is important to follow proper instructions when administering an enema to avoid injury or discomfort. Possible side effects of enemas may include cramping, bloating, nausea, or electrolyte imbalances. If you have any health concerns or conditions that may be affected by an enema, it is recommended to consult with a healthcare professional before using one.

Ulcerative colitis is a type of inflammatory bowel disease (IBD) that affects the lining of the large intestine (colon) and rectum. In ulcerative colitis, the lining of the colon becomes inflamed and develops ulcers or open sores that produce pus and mucous. The symptoms of ulcerative colitis include diarrhea, abdominal pain, and rectal bleeding.

The exact cause of ulcerative colitis is not known, but it is thought to be related to an abnormal immune response in which the body's immune system attacks the cells in the digestive tract. The inflammation can be triggered by environmental factors such as diet, stress, and infections.

Ulcerative colitis is a chronic condition that can cause symptoms ranging from mild to severe. It can also lead to complications such as anemia, malnutrition, and colon cancer. There is no cure for ulcerative colitis, but treatment options such as medications, lifestyle changes, and surgery can help manage the symptoms and prevent complications.

The rectum is the lower end of the digestive tract, located between the sigmoid colon and the anus. It serves as a storage area for feces before they are eliminated from the body. The rectum is about 12 cm long in adults and is surrounded by layers of muscle that help control defecation. The mucous membrane lining the rectum allows for the detection of stool, which triggers the reflex to have a bowel movement.

A colonoscopy is a medical procedure used to examine the large intestine, also known as the colon and rectum. It is performed using a flexible tube with a tiny camera on the end, called a colonoscope, which is inserted into the rectum and gently guided through the entire length of the colon.

The procedure allows doctors to visually inspect the lining of the colon for any abnormalities such as polyps, ulcers, inflammation, or cancer. If any polyps are found during the procedure, they can be removed immediately using special tools passed through the colonoscope. Colonoscopy is an important tool in the prevention and early detection of colorectal cancer, which is one of the leading causes of cancer-related deaths worldwide.

Patients are usually given a sedative to help them relax during the procedure, which is typically performed on an outpatient basis in a hospital or clinic setting. The entire procedure usually takes about 30-60 minutes to complete, although patients should plan to spend several hours at the medical facility for preparation and recovery.

The intestinal mucosa is the innermost layer of the intestines, which comes into direct contact with digested food and microbes. It is a specialized epithelial tissue that plays crucial roles in nutrient absorption, barrier function, and immune defense. The intestinal mucosa is composed of several cell types, including absorptive enterocytes, mucus-secreting goblet cells, hormone-producing enteroendocrine cells, and immune cells such as lymphocytes and macrophages.

The surface of the intestinal mucosa is covered by a single layer of epithelial cells, which are joined together by tight junctions to form a protective barrier against harmful substances and microorganisms. This barrier also allows for the selective absorption of nutrients into the bloodstream. The intestinal mucosa also contains numerous lymphoid follicles, known as Peyer's patches, which are involved in immune surveillance and defense against pathogens.

In addition to its role in absorption and immunity, the intestinal mucosa is also capable of producing hormones that regulate digestion and metabolism. Dysfunction of the intestinal mucosa can lead to various gastrointestinal disorders, such as inflammatory bowel disease, celiac disease, and food allergies.

Functional colonic diseases are a group of disorders of the large intestine (colon) that do not have a structural or biochemical explanation. They are characterized by chronic and often intermittent symptoms, such as abdominal pain, bloating, and changes in bowel habits, but do not show any visible abnormalities or damage to the tissue of the colon during routine examination or testing.

The most common functional colonic diseases include:

1. Irritable Bowel Syndrome (IBS): A disorder characterized by recurrent abdominal pain, bloating, and changes in bowel habits, such as constipation or diarrhea.
2. Functional Constipation: A condition where a person experiences difficult or infrequent bowel movements, but there is no obvious structural or biochemical cause.
3. Functional Diarrhea: A disorder characterized by frequent loose stools, but without any underlying structural or biochemical abnormalities.
4. Abdominal Bloating: A condition where the belly feels full and tight, often accompanied by discomfort or pain, but without any visible distention.
5. Functional Abdominal Pain Syndrome: A disorder characterized by chronic or recurrent abdominal pain that is not associated with any structural or biochemical abnormalities.

The exact cause of functional colonic diseases is unknown, but they are believed to be related to a combination of factors, including genetics, environmental factors, altered gut motility, visceral hypersensitivity, and psychological factors such as stress and anxiety. Treatment typically involves lifestyle modifications, such as changes in diet and exercise, and medication to manage symptoms.

Colonic neoplasms refer to abnormal growths in the large intestine, also known as the colon. These growths can be benign (non-cancerous) or malignant (cancerous). The two most common types of colonic neoplasms are adenomas and carcinomas.

Adenomas are benign tumors that can develop into cancer over time if left untreated. They are often found during routine colonoscopies and can be removed during the procedure.

Carcinomas, on the other hand, are malignant tumors that invade surrounding tissues and can spread to other parts of the body. Colorectal cancer is the third leading cause of cancer-related deaths in the United States, and colonic neoplasms are a significant risk factor for developing this type of cancer.

Regular screenings for colonic neoplasms are recommended for individuals over the age of 50 or those with a family history of colorectal cancer or other risk factors. Early detection and removal of colonic neoplasms can significantly reduce the risk of developing colorectal cancer.

Colonic polyps are abnormal growths that protrude from the inner wall of the colon (large intestine). They can vary in size, shape, and number. Most colonic polyps are benign, meaning they are not cancerous. However, some types of polyps, such as adenomas, have a higher risk of becoming cancerous over time if left untreated.

Colonic polyps often do not cause any symptoms, especially if they are small. Larger polyps may lead to symptoms like rectal bleeding, changes in bowel habits, abdominal pain, or iron deficiency anemia. The exact cause of colonic polyps is not known, but factors such as age, family history, and certain medical conditions (like inflammatory bowel disease) can increase the risk of developing them.

Regular screening exams, such as colonoscopies, are recommended for individuals over the age of 50 to detect and remove polyps before they become cancerous. If you have a family history of colonic polyps or colorectal cancer, your doctor may recommend earlier or more frequent screenings.

Hirschsprung disease is a gastrointestinal disorder that affects the large intestine, specifically the section known as the colon. This condition is congenital, meaning it is present at birth. It occurs due to the absence of ganglion cells (nerve cells) in the bowel's muscular wall, which are responsible for coordinating muscle contractions that move food through the digestive tract.

The affected segment of the colon cannot relax and propel the contents within it, leading to various symptoms such as constipation, intestinal obstruction, or even bowel perforation in severe cases. Common diagnostic methods include rectal suction biopsy, anorectal manometry, and contrast enema studies. Treatment typically involves surgical removal of the aganglionic segment and reattachment of the normal colon to the anus (known as a pull-through procedure).

Proto-oncogene proteins c-RET are a group of gene products that play crucial roles in the development and functioning of the nervous system, as well as in other tissues. The c-RET proto-oncogene encodes a receptor tyrosine kinase, which is a type of enzyme that helps transmit signals from the outside to the inside of cells. This receptor is activated by binding to its ligands, leading to the activation of various signaling pathways that regulate cell growth, differentiation, and survival.

Mutations in the c-RET proto-oncogene can lead to its overactivation, resulting in the conversion of this gene into an oncogene. Oncogenes are genes that have the potential to cause cancer when they are mutated or abnormally expressed. Activating mutations in c-RET have been implicated in several types of human cancers, including multiple endocrine neoplasia type 2 (MEN2), papillary thyroid carcinoma, and certain types of lung and kidney cancers. These mutations can lead to the constitutive activation of c-RET, resulting in uncontrolled cell growth and tumor formation.

The enteric nervous system (ENS) is a part of the autonomic nervous system that directly controls the gastrointestinal tract, including the stomach, small intestine, colon, and rectum. It is sometimes referred to as the "second brain" because it can operate independently of the central nervous system (CNS).

The ENS contains around 500 million neurons that are organized into two main plexuses: the myenteric plexus, which lies between the longitudinal and circular muscle layers of the gut, and the submucosal plexus, which is located in the submucosa. These plexuses contain various types of neurons that are responsible for regulating gastrointestinal motility, secretion, and blood flow.

The ENS can communicate with the CNS through afferent nerve fibers that transmit information about the state of the gut to the brain, and efferent nerve fibers that carry signals from the brain back to the ENS. However, the ENS is also capable of functioning independently of the CNS, allowing it to regulate gastrointestinal functions in response to local stimuli such as food intake, inflammation, or infection.

SOXE transcription factors are a subgroup of the SOX (SRY-related HMG box) family of proteins, which are involved in various developmental processes, including cell fate specification and differentiation. The SOXE group includes SOX8, SOX9, and SOX10, all of which contain a conserved high mobility group (HMG) box DNA-binding domain. They play crucial roles in the development of several tissues, such as the nervous system, skeletal system, and urogenital system.

SOXE transcription factors are known to regulate gene expression by binding to specific DNA sequences, often acting in combination with other transcription factors to control various cellular processes. Dysregulation of SOXE transcription factors has been implicated in several human diseases, including cancer and neurodevelopmental disorders.

Glial cell line-derived neurotrophic factor (GDNF) receptors are a group of proteins found on the surface of certain cells in the body that bind to GDNF and transmit signals into the cell, thereby activating various cellular responses. GDNF is a type of signaling protein called a neurotrophic factor, which supports the survival and development of neurons (nerve cells).

The GDNF receptor complex consists of two main components: the Ret tyrosine kinase receptor and a glycosylphosphatidylinositol (GPI)-anchored coreceptor called GDNF family receptor alpha (GFRα). There are four different GFRα isoforms (GFRα1, GFRα2, GFRα3, and GFRα4) that can form complexes with Ret and bind to different members of the GDNF ligand family.

When GDNF binds to the GFRα-Ret complex, it induces a conformational change leading to Ret autophosphorylation and activation of various downstream signaling pathways, including Ras/MAPK, PI3K/Akt, and PLCγ. These signaling cascades ultimately regulate cell survival, proliferation, differentiation, and migration, depending on the cellular context.

GDNF receptors are widely expressed in various tissues, but they have crucial roles in the nervous system, where they support neuronal survival, promote axon growth and guidance, and maintain synaptic plasticity. Dysregulation of GDNF signaling has been implicated in several neurological disorders, such as Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS).

The Endothelin B (ETB) receptor is a type of G protein-coupled receptor that binds to endothelin, a potent vasoconstrictor peptide. ETB receptors are expressed in various tissues, including vascular endothelial cells and smooth muscle cells. When endothelin binds to the ETB receptor, it can cause both vasodilation and vasoconstriction, depending on the location of the receptor. In endothelial cells, activation of ETB receptors leads to the production of nitric oxide, a potent vasodilator. However, in vascular smooth muscle cells, activation of ETB receptors can cause vasoconstriction by increasing intracellular calcium levels.

ETB receptors have also been implicated in various physiological and pathophysiological processes, including cardiovascular function, kidney function, and neurotransmission. In the cardiovascular system, ETB receptors play a role in regulating blood pressure and vascular remodeling. In the kidneys, they are involved in the regulation of sodium and water balance. Additionally, ETB receptors have been implicated in the development of pulmonary hypertension, heart failure, and chronic kidney disease.

Overall, Endothelin B receptors play a critical role in regulating various physiological processes, and their dysregulation has been associated with several pathological conditions.

Waardenburg Syndrome is a genetic disorder that affects the development of melanin, a pigment responsible for hair, skin, and eye color. Named after the Dutch ophthalmologist Petrus Waardenburg who first described it in 1907, this syndrome is characterized by distinctive physical features and hearing loss.

There are four types of Waardenburg Syldrome (WS1, WS2, WS3, and WS4), each with varying degrees of symptoms. Common features include:

1. Differential coloring of the hair, skin, and eyes (poliosis, vitiligo, and heterochromia)
2. Distinctive facial features (wide-set eyes, broad nasal root, and a high arched or cleft palate)
3. Hearing loss, which can be unilateral (one-sided) or bilateral (both-sided), conductive, sensorineural, or mixed
4. Pigmentary changes in the iris, such as different colors between the eyes or within one eye
5. Sometimes, musculoskeletal abnormalities and/or developmental delays

WS1 and WS2 are more common than WS3 and WS4. The genetic causes of Waardenburg Syndrome involve mutations in several different genes associated with melanin production and transport. These include PAX3, MITF, SNAI2, EDN3, and EDNRB.

Diagnosis is typically based on clinical findings, including physical features and hearing tests. Genetic testing can confirm the diagnosis and help determine the specific type of Waardenburg Syndrome. Treatment usually involves addressing individual symptoms, such as using hearing aids or cochlear implants for hearing loss and managing any skin or eye concerns.

I'm sorry for any confusion, but "Kentucky" is not a medical term or condition. It is a geographical location, being the name of a state in the United States. If you have any questions related to medical conditions or terminology, I would be happy to try and help answer those for you!

A metagenome is the collective genetic material contained within a sample taken from a specific environment, such as soil or water, or within a community of organisms, like the microbiota found in the human gut. It includes the genomes of all the microorganisms present in that environment or community, including bacteria, archaea, fungi, viruses, and other microbes, whether they can be cultured in the lab or not. By analyzing the metagenome, scientists can gain insights into the diversity, abundance, and functional potential of the microbial communities present in that environment.

Medical Definition of Microbiota:

The community of microorganisms, including bacteria, viruses, fungi, and other microscopic life forms, that inhabit a specific environment or body part. In the human body, microbiota can be found on the skin, in the mouth, gut, and other areas. The largest concentration of microbiota is located in the intestines, where it plays an essential role in digestion, immune function, and overall health.

The composition of the microbiota can vary depending on factors such as age, diet, lifestyle, genetics, and environmental exposures. Dysbiosis, or imbalance of the microbiota, has been linked to various health conditions, including gastrointestinal disorders, allergies, autoimmune diseases, and neurological disorders.

Therefore, maintaining a healthy and diverse microbiota is crucial for overall health and well-being. This can be achieved through a balanced diet, regular exercise, adequate sleep, stress management, and other lifestyle practices that support the growth and maintenance of beneficial microorganisms in the body.

The gastrointestinal (GI) tract, also known as the digestive tract, is a continuous tube that starts at the mouth and ends at the anus. It is responsible for ingesting, digesting, absorbing, and excreting food and waste materials. The GI tract includes the mouth, esophagus, stomach, small intestine (duodenum, jejunum, ileum), large intestine (cecum, colon, rectum, anus), and accessory organs such as the liver, gallbladder, and pancreas. The primary function of this system is to process and extract nutrients from food while also protecting the body from harmful substances, pathogens, and toxins.

Volatile fatty acids (VFA) are a type of fatty acid that have a low molecular weight and are known for their ability to evaporate at room temperature. They are produced in the body during the breakdown of carbohydrates and proteins in the absence of oxygen, such as in the digestive tract by certain bacteria.

The most common volatile fatty acids include acetic acid, propionic acid, and butyric acid. These compounds have various roles in the body, including providing energy to cells in the intestines, modulating immune function, and regulating the growth of certain bacteria. They are also used as precursors for the synthesis of other molecules, such as cholesterol and bile acids.

In addition to their role in the body, volatile fatty acids are also important in the food industry, where they are used as flavorings and preservatives. They are produced naturally during fermentation and aging processes, and are responsible for the distinctive flavors of foods such as yogurt, cheese, and wine.

Collagen Type VI is a type of collagen that is widely expressed in various tissues, including skeletal muscle, skin, and blood vessels. It is a major component of the extracellular matrix and plays important roles in maintaining tissue structure and function. Collagen Type VI forms microfilaments that provide structural support to the basement membrane and regulate cell-matrix interactions. Mutations in the genes encoding collagen Type VI can lead to several inherited connective tissue disorders, such as Bethlem myopathy and Ullrich congenital muscular dystrophy.

Butyrates are a type of fatty acid, specifically called short-chain fatty acids (SCFAs), that are produced in the gut through the fermentation of dietary fiber by gut bacteria. The name "butyrate" comes from the Latin word for butter, "butyrum," as butyrate was first isolated from butter.

Butyrates have several important functions in the body. They serve as a primary energy source for colonic cells and play a role in maintaining the health and integrity of the intestinal lining. Additionally, butyrates have been shown to have anti-inflammatory effects, regulate gene expression, and may even help prevent certain types of cancer.

In medical contexts, butyrate supplements are sometimes used to treat conditions such as ulcerative colitis, a type of inflammatory bowel disease (IBD), due to their anti-inflammatory properties and ability to promote gut health. However, more research is needed to fully understand the potential therapeutic uses of butyrates and their long-term effects on human health.

No FAQ available that match "colonic diseases functional"

No images available that match "colonic diseases functional"